BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20022497)

  • 1. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L.
    Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
    Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
    Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of 8-substituted 2-5A analogues.
    Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
    Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.
    Kitade Y; Nakata Y; Hirota K; Maki Y; Pabuccuoglu A; Torrence PF
    Nucleic Acids Res; 1991 Aug; 19(15):4103-8. PubMed ID: 1714563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
    Yoshimura A; Nakanishi M; Yatome C; Kitade Y
    J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for recognition of 2',5'-linked oligoadenylates by the N-terminal ankyrin repeat domain of human ribonuclease L.
    Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
    Nucleic Acids Symp Ser (Oxf); 2005; (49):323-4. PubMed ID: 17150764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
    Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH
    J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of analogs of 2-5A determined using the core-cellulose assay for 2-5A-dependent RNase.
    Krause D; Lesiak K; Imai J; Sawai H; Torrence PF; Silverman RH
    Prog Clin Biol Res; 1985; 202():133-9. PubMed ID: 3832069
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Methyladenosine-Substituted 2',5'-oligoadenylates: conformations, 2-5A binding and catalytic activities with human ribonuclease L.
    Kitade Y; Wakana M; Tsuboi T; Yatome C; Bayly SF; Player MR; Torrence PF
    Bioorg Med Chem Lett; 2000 Feb; 10(4):329-31. PubMed ID: 10714492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
    Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
    EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.